IPC signs MoUs with PMBI and NIPER Hajipur to enhance drug quality, research, and patient safety

Ipc Signs Mous With Pmbi And Niper Hajipur To Enhance Drug Quality, Research, And Patient Safety

View April 2026 Crrent Affairs

The Indian Pharmacopoeia Commission (IPC) has signed Memoranda of Understanding (MoUs) with the Pharmaceuticals & Medical Devices Bureaof India (PMBI) and the National Institute of Pharmaceutical Education and Research (NIPER), Hajipur. 

These collaborations aim to strengthen drug quality assurance, promote pharmacovigilance, enhance pharmaceutical research, and ensure patient safety across India.

IPC–PMBI Collaboration (Jan Aushadhi Focus)

Random sampling of Jan Aushadhi medicines for quality testing by IPC.

Promotion of National Formulary of India (NFI) for rational drug use.

Strengthening Pharmacovigilance Programme of India (PvPI) via QR codes and helpline for ADR reporting.

Training and awareness programs for pharmacists and stakeholders.

IPC–NIPER Hajipur Collaboration (Research Focus)

Joint research on impurity profiling (including genotoxic impurities like nitrosamines).

Development of analytical methods and quality control protocols.

Creation of standards for biologics, biosimilars, and gene/cell therapies.

Academic exchange, training, internships, and fellowships.

Overall Impact

Strengthening drug quality assurance framework in India.

Promoting rational use of medicines and patient safety.

Enhancing India’s global position in pharmaceutical standards and regulatory science.

Key Facts:

Indian Pharmacopoeia Commission (IPC)

Autonomous body under Ministry of Health & Family Welfare

Responsible for setting drug standards (Indian Pharmacopoeia)

PMBI (Pharmaceuticals & Medical Devices Bureaof India)

Implements Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

Ensures availability of affordable generic medicines

Chairman: P. K. Pradhan

Headquarters: Ghaziabad

NIPER Hajipur:

Institute of National Importance (est. 2007)

Under Ministry of Chemicals & Fertilizers

Focus: pharmaceutical education & research

Pharmacovigilance Programme of India (PvPI)

Monitors Adverse Drug Reactions (ADR)

Coordinated by IPC

Jan Aushadhi Kendras (PMBJKs)

Provide affordable generic medicines to the public

Established: 2007

Director: Prof. Ruckmani Kandasamy

Call Us Now
98403 94477